These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 16681662

  • 1. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV.
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV.
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV.
    Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
    El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied MM, Gouda HM.
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
    [Abstract] [Full Text] [Related]

  • 9. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
    Huggins RH, Henderson MD, Mulekar SV, Ozog DM, Kerr HA, Jabobsen G, Lim HW, Hamzavi IH.
    J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
    [Abstract] [Full Text] [Related]

  • 10. Koebnerization of donor site in unilateral vitiligo patients, treated successfully by autologous, noncultured melanocyte-keratinocyte (MK) cell transplantation.
    Mulekar SV, Al Eissa A, Asaad M.
    Clin Exp Dermatol; 2005 Jul; 30(4):445-6. PubMed ID: 15953098
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM, Abd Elazim NE, Abdel-Motaleb AA, Mohammed RAA, Tohamy AMA.
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [Abstract] [Full Text] [Related]

  • 19. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI, Ghwish B, Al Issa A, Mulekar SV.
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [Abstract] [Full Text] [Related]

  • 20. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
    Sahni K, Parsad D, Kanwar AJ.
    Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.